Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

"Influx" of atypical myopathy cases
horse
Research has linked toxins in the seeds of sycamore trees to atypical myopathy.
Vets advise restricted access to sycamore

Newmarket vets have seen "an influx" of horses with equine atypical myopathy (AM) and are warning owners to restrict access to sycamore trees, which have been linked to the potentially lethal condition.

Over the past week, Rossdales Equine Hospital says it has seen several cases of the muscle disease, all of which were sycamore related.

Past research suggests AM is likely to be caused by ingestion of sycamore tree seeds, which contain the toxin hypoglycin-A. The condition is thought to be particularly common after periods of wet and windy weather.

Rossdales' internal medicine specialist, Professor Celia Marr, said recent weather conditions are likely to have been "an additional trigger factor."

She added: "We would recommend removing access to sycamore and providing supplementary feed during bad weather - both are appropriate measures."

AM causes the destruction of muscle tissue, including the heart. Dark coloured urine is "a characteristic sign," said Professor Marr. The presenting sign in about 10 to 20 per cent of patients is sudden stiffness or difficulty swallowing.

Other signs include muscle tremors, breathing problems, sudden weakness and low body temperature.

Swift treatment and careful management is essential in AM cases.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.